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Background: Previous experimental studies have reported that pistachios can elicit positive effects 29 
on lipid profile, blood pressure, and inflammation; however, a meta-analysis of the available 30 
evidence has yet to be performed. Objective:  the aim of this study was to conduct  systematic 31 
review and meta-analysis of the effect of pistachio enriched diets on cardiometabolic risk factors, 32 
such as weight, BMI, blood pressure, serum lipids, blood glucose, and inflammatory biomarkers. 33 
Design: A literature search was carried out for RCTs in medical databases, including 34 
PubMed/MEDLINE, Scopus, and Cochrane databases, with no time limitation up to August 2019, 35 
and conducted in accordance with the Preferred Reporting Items of Systematic Reviews and Meta-36 
Analysis guidelines. Results: 11 RCTs, with 506 participants, that reported the effect of pistachios 37 
consumption on cardiometabolic risk factors were included in this systematic review and meta-38 
analysis. Our findings indicated that pistachios consumption significantly reduced FBS (WMD: -39 
3.73, 95% CI: -6.99, -0.46, I2=99%), TC/HDL (WMD: -0.46, 95% CI: -0.76, -0.15, I2=95%), 40 
LDL/HDL (WMD: -0.24, 95% CI: -0.38, -0.11, I2=96%), HbA1C (WMD: -0.14, 95% CI: -0.26, -41 
0.02, I2=60%), Insulin (WMD: -2.43, 95% CI: -4.85, -0.001, I2=58%), SBP (WMD: -3.10, 95% 42 
CI: -5.35, -0.85, I2=63%), and MDA (WMD: -0.36, 95% CI: -0.49, -0.23, I2=0%). Importantly, we 43 
did not observe adverse effects of pistachios consumption on BMI or blood pressure. Conclusion: 44 
This systematic review and meta-analysis demonstrates that pistachios consumption can elicit a 45 
beneficial effect on some cardiometabolic risk factors. Further examination is required to 46 
determine the effect of pistachios consumption on further metabolic risk factors.  47 




Introduction:  52 
Cardio metabolic risk factors, such as raised blood sugar, blood pressure, blood lipids, obesity, and 53 
inflammation are well established precursors to CVD (1). There is a considerable body of evidence 54 
that has shown consuming nuts, in particular tree nuts, may yield beneficial effects on cardio 55 
metabolic risk factors (2-9). The results of a previous systematic review and meta-analysis of 18 56 
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cohort studies highlighted that the consumption of nuts, seven times per week, was associated with 57 
a decrease in the incidence of ischemic heart disease and CVD (10). Moreover, a recent pooled 58 
analysis of 25 clinical studies on the consumption of various types of nut, with an average daily 59 
intake of 67 g, reported a dose-mediated response in reducing cholesterol levels (11). The United 60 
States food and drug administration (FDA) has approved health claims that consuming 1.5g, once 61 
per day, of macadamia nuts, walnuts, or tree nuts can help reduce the risk of coronary heart disease 62 
(www.fda.gov). The apparent beneficial effects of nuts consumption on lipid profile could be 63 
manifest from their unsaturated fats, phytostrols, and fiber content, respectively, in addition to the 64 
lysine to arginine ratio of nuts (12, 13). Relative to other tree nuts, pistachios contain fewer 65 
calories, higher essential amino acids, and, according US department of agriculture database, 66 
possess the highest phytosterols and potassium content; contextually, 100 g of pistachios contains 67 
560 kcal, 20.16 g protein, 45.32 g fats, 1025 mg potassium and approximately 214 mg phytosterols 68 
(12). Recently, it was demonstrated that pistachios contain the highest concentration of B-carotene, 69 
Ƴ-tocopherol, and lutein/zeaxanthin among nuts (14).  70 
The potential for pistachio enriched diets to positively influence blood pressure may be attributed 71 
to their potassium, magnesium, arginine, and polyphenol content (15). Given that pistachios 72 
contain phytosterols, such as B-sitosterol, and high amounts of polyphenols, such as 73 
lutein/zeaxanthin, they may promote an inflammatory and oxidative state, leading to a reduction 74 
in oxidized LDL cholesterol, and vascular inflammation, that are key events in atherosclerosis and 75 
CVD development (16-18). Previous experimental studies have reported that pistachios can elicit 76 
a wide range of effects on lipid profile, blood pressure, and inflammation; however, a meta-77 
analysis of the available evidence has yet to be performed. We hypothesized that regular 78 
consumption of the pistachios in a healthy diet would improve cardiovascular risk factors and 79 
vascular function. Thus, the aim of this study was to conduct  systematic review and meta-analysis 80 
of the effect of pistachio enriched diets on cardiometabolic risk factors. 81 
Methods 82 
The Preferred Reporting Items of Systematic Reviews and Meta-Analysis guidelines )PRISMA 83 
((19) were followed in the conducting of this meta-analysis. (Supplemental table and figure) 84 
Search strategy 85 
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A literature search was carried out by two independent reviewers (JR) and (MGH) in medical 86 
databases, including PubMed/MEDLINE, Scopus, and Cochrane databases, with no time 87 
limitation up to August 2019. The following Medical Subject Headings (MeSH) terms were 88 
selected to search the databases, keyword group 1: “pistachio”; “pistacia nut tree”, “pistachios nut 89 
tree”; keyword group 2: “blood pressure”, “serum lipids”, “blood glucose”, “CVD”, “cholesterol”, 90 
“lipoproteins, HDL”, “lipoproteins, LDL”, “triglyceride”, “glucose tolerance test”, “insulin”, 91 
“blood glucose”, “insulin resistance”, “low density lipoprotein”, “high density lipoprotein”, “TG”, 92 
“TC”, “GTT”, “FBS”, “FBG”, “FPG”, “CRP”, “IL-6”, “FMD”, “TNF-alpha”, “ICAM-1”, 93 
“VCAM-1”, “fasting insulin”, “fasting blood sugar”, “fasting blood glucose”, “inflammation”, 94 
“fasting plasma glucose”, “insulin sensitivity”, “blood sugar”, “lipid profile”, “serum lipid”, 95 
“blood pressure”, “hypertension”, “cardiovascular disease”, “coronary disease”, “coronary artery 96 
disease”, “CVD”, coronary artery disease (“CAD”), “obesity”, and “weight”, ; and keyword group 97 
3: “randomized”, “intervention”, “controlled trial”, “random”, and “placebo”. We searched 98 
keyword group 1 in combination with both keyword groups 2 and 3. The search strategy can be 99 
found in Supplementary figure 1. In primary screening, the abstracts and titles of selected studies 100 
were read to identify relevant information. Following this, 25 articles remained , and were assessed 101 
for eligibility, where the full-text of each article was read by 2 independent reviewers (MGH and 102 
SM). Finally, 11 articles were included in the meta-analysis. In order to identify additional studies, 103 
all reference lists of eligible articles, reviews, and meta-analyses were scrutinized. Unpublished 104 
articles, conference papers, and theses were not included in this study. To identify new articles that 105 
may have been published after our search, the PubMed’s email alert service was created. 106 
 107 
Eligibility criteria 108 
The PICOS (patients, intervention, comparator, outcome, study design) criteria was used to 109 
establish study eligibility. All clinical trials were included in this meta-analysis if they fulfilled the 110 
following criteria: 1) the study design was RCT, 2) the intervention was pistachios consumption, 111 
3) conducted among adults (age ≥ 18 years), 4) assessed lipid profile, blood pressure, and 112 
inflammation biomarkers as outcome, 5) were published in English. Studies were excluded if they 113 
had the following exclusion criteria: 1) non-RCTs studies, 2) conducted on non-humans, 3) 114 
conducted on children, 4) studies without a placebo group, 5) examined the effect of other 115 
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interventions along with pistachios in cases but not in placebo group, 6) lipid profile or blood 116 
pressure or inflammation biomarkers were not reported at baseline and end of the intervention, 7) 117 
uncontrolled RCTs. 118 
 119 
Data extraction 120 
Data scanning and extraction were performed by two independent researchers (JR and MGH) and 121 
discrepancies were discussed and eventually resolved by a senior author (MR). The following 122 
information was extracted: first author’s last name, year of publication, type of study population, 123 
number of cases and controls, participants’ gender, geographic location, study design, intervention 124 
duration, type and dose of intervention and placebo, and Mean and SD of outcome (BMI, FBS, 125 
LDL-C, HDL-C, TG, TC, TC/HDL, LDL/HDL, INSULIN, HBA1C, HOMA-IR, SBP,DBP, 126 
FMD) in baseline study and post-intervention. Some ratios which include in this meta-analysis 127 
such as TC/HDL and LDL/HDL were obtained from the included studies.  128 
 129 
Statistical analysis 130 
Stata software (version 14) was used to perform all statistical analyses. The following formula: 131 
SD2 baseline + SD2 final – (2 R* SD baseline + SD final) (20) was used to calculate the SD change for 132 
mean difference in studies that did not report such data. DerSimonian and Laird  random-effects 133 
model was utilized to calculate weighted mean difference (WMD). The I2 index and Q test were 134 
calculated to evaluate heterogeneity across included studies (21). Meta regression analysis, based 135 
on duration of intervention, was used to identify the source of heterogeneity among included trials. 136 
The funnel plot, Egger’s weighted regression tests, and Begg’s rank correlation were conducted to 137 
evaluation publication bias between studies. Statistical significance was accepted at P <0.05. 138 
Sensitivity analysis was conducted to evaluate the effect of each study on combined results. 139 
Results: 140 
In our initial search of PubMed, Scopus, and Cochrane Library, 327 articles were identified 141 
(Supplementary Figure 1). After removing duplicates, 280 articles remained. Based on initial title 142 
and abstract inspection, 255 articles were excluded, and 25 articles were retained for more detailed 143 
evaluation. Fourteen articles were excluded based on the following reason: 1) included pistachios 144 
oil or extract (n=2), 2) In Vitro trial (n=2), 3) study intervention combined with other foods and 145 
supplements (n=3), 4) No SE/SD/CI reported (n=4) and 5) Not reporting outcomes of interest 146 
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(n=3). Finally, 11 articles with 506 participants were included in this systematic review and meta-147 
analysis(6, 22-31). 148 
Study characteristics 149 
Studies included in this meta-analysis were published between 2006 and 2015, with sample sizes 150 
ranging from 28 to 90, with an average of 46 participants in each study. General characteristics of 151 
the included studies are presented in Table 1. Two of included studies were conducted in Turkey 152 
(6, 23), four in the USA (22, 25, 29, 31), one in China (24), two in India (26, 30), one in Iran (28), 153 
and one in Spain (28). The mean age of participants was 45 years, with a mean duration of the 154 
interventions of 9.7 weeks, ranging from 3 to 24 weeks. Table 2 details the quality assessment of 155 
the studies. Quality assessment of the included studies was performed using the Cochrane 156 
Collaboration’s tool for assessing risk of bias (32). Seven items were scored with 3 rating 157 
categories for each item, including low risk of bias, unclear risk of bias, and high risk of bias. An 158 
item was scored as high risk, unless there was sufficient information on it. Overall quality was 159 
obtained by summing the scores for each study. Two authors (JR and SM) scored the articles, and 160 
all of the included studies were regarded as possessing ‘fair’ or ‘good’ overall quality.  161 
Meta-analysis results 162 
Combined analysis of the effect of pistachio consumption on BMI, weight, WC, FBS, LDL, HDL, 163 
TG, TC, TC/HDL, LDL/HDL, HbA1C, Insulin, HOMA-IR, systolic blood pressure, diastolic 164 
blood pressure, CRP, FMD, and MDA are presented in figure 1. Following pistachio consumption 165 
there was: An increasing effect on weight (WMD: 0.19 kg, 95% CI: 0.12, 0.26, I2=0%); whist there 166 
was no overall effect on BMI (WMD: -0.21 kg/m2, 95% CI: -0.77, 0.34, I2=65%), WC (WMD: 167 
0.67 cm, 95% CI: -0.27, 1.61, I2=42%), LDL (WMD: -2.40 mg/dl, 95% CI: -5.70, 0.90, I2=92%), 168 
HDL (WMD: 2.34 mg/dl, 95% CI: -3.76, 8.44, I2=99%), TG (WMD: -8.62 mg/dl, 95% CI: -20.11, 169 
2.86, I2=93%), TC (WMD: -6.03 mg/dl, 95% CI: -12.38, 0.31, I2=95%), HOMA-IR (WMD: -0.73, 170 
95% CI: -1.97, 0.51, I2=94%), DBP (WMD: -0.83 mmHg, 95% CI: -2.75, 1.09, I2=63%), CRP 171 
(WMD: -0.04 mg/dl, 95% CI: -0.43, 0.36, I2=42%), and FMD (WMD: 0.94%, 95% CI: -0.99, 2.86, 172 
I2=83%).  173 
Furthermore, we found that there was a lowering effect on FBS (WMD: -3.73 mg/dl, 95% CI: -174 
6.99, -0.46, I2=99%), TC/HDL (WMD: -0.46, 95% CI: -0.76, -0.15, I2=95%), LDL/HDL (WMD: 175 
-0.24, 95% CI: -0.38, -0.11, I2=96%), HbA1C (WMD: -0.14%, 95% CI: -0.26, -0.02, I2=60%), 176 
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Insulin (WMD: -2.43 mLU/mL, 95% CI: -4.85, -0.001, I2=58%), SBP (WMD: -3.10 mmHg, 95% 177 
CI: -5.35, -0.85, I2=63%), and MDA (WMD: -0.36 nmol/l, 95% CI: -0.49, -0.23, I2=0%). 178 
Meta-regression analysis, based on duration of intervention, was only significant for BMI 179 
(coef=0.18, p=0.01) and FMD (coef=0.69, p=0.05) (Supplemental Fig 2). Sensitivity analysis 180 
demonstrated no significant differences were evident beyond the limit of the 95% CI 181 
Publication bias 182 
Although the funnel plots highlighted some visual asymmetry between included studies in some 183 
outcomes (Supplemental Fig 3), the Egger’s and Begg’s tests did not show any publication bias 184 
for BMI (p=0.13, p=0.49, asymmetry), WC (p=0.44, p=0.49, symmetry), FBS (p=0.45, p=0.53, 185 
symmetry), LDL (p=0.54, p=0.67, asymmetry), HDL (p=0.28, p=0.45, asymmetry), TG (p=0.84, 186 
p=0.21, asymmetry), TC (p=0.70, p=0.99, asymmetry), TC-HDL (p=0.14, p=0.62, asymmetry), 187 
LDL-HDL (p=0.80, p=0.60, asymmetry), HbA1C (p=0.13, p=0.17, asymmetry), Insulin (p=0.08, 188 
p=0.85, asymmetry), HOMA-IR (p=0.30, p=0.60, asymmetry), SBP (p=0.43, p=0.05, asymmetry), 189 
DBP (p=0.21, p=0.49, asymmetry), CRP (p=0.21, p=0.62, asymmetry), and FMD (p=0.26, p=0.07, 190 
asymmetry), respectively. Because of the significant Egger’s test for weight (p=0.01, asymmetry), 191 
Trim and filled analysis was conducted to detect for potential publication bias. Accordingly, the test 192 
did not highlight any publication bias (Effect size: 0.19, CI: 0.12-0.26). 193 
 194 
Discussion 195 
To our knowledge, this is the first study to systematically review and meta-analyze the effects of 196 
pistachios consumption on the cardio metabolic risk factors.  197 
Our findings indicated that pistachios consumption significantly reduced FBS, TC/HDL, 198 
LDL/HDL, HbA1C, insulin, SBP, and MDA levels. Importantly, we did not observe any adverse 199 
effects of pistachios consumption on BMI or blood pressure. However, pistachios consumption 200 
did result in a significant increase in weight. Nuts, especially pistachios, contain a variety of 201 
micronutrients that can exert a protective effect against chronic diseases. Indeed, consistent with 202 
our findings, several previous studies have also reported the cardio metabolic protective effects of 203 
the nuts (33, 34).  204 
Body composition 205 
The results of the current meta-analysis indicated that pistachios intake has no significant effects 206 
on BMI and WC, however, may increase weight significantly; although this change is not clinically 207 
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significant. Interestingly, studies that reported weight and body mass index differed in sample 208 
sizes, potentially explaining why weight, but not BMI, was significantly altered. Moreover, in a 209 
previous study, it was reported that a decrease in WC and BMI without significant reduction body 210 
weight may indicate preferential loss of abdominal fat as shown by trend toward decrease in 211 
subcutaneous abdominal adipose tissue (SCAT) (26). It is widely accepted that nut intake, due to 212 
its high fat content, can lead to weight gain in the general population, especially in obese subjects 213 
and those with metabolic syndrome (24). However, in the present study, changes were only 214 
significant in weight, and no significant change was observed in BMI and WC. Nuts, especially 215 
pistachios, are high energy-dense foods and over-consumption can, therefore, lead to weight gain. 216 
Previous research has shown that the energy density of pistachios is 23.7 kJ/g, as calculated using 217 
the Atwater general factors (35). However, pistachios have a low glycemic index score and it has 218 
been shown that concomitant consumption of pistachio with high carbohydrate diets can partially 219 
inhibit carbohydrate absorption (36). 220 
 221 
Glycaemia control 222 
Our results revealed that pistachios consumption may improve glycaemia. Indeed, in our study, 223 
pistachios consumption led to a significant improvement in most of the reported glycemic control 224 
markers, except for HOMA-IR. However, the heterogeneity was high in FBS (99.5%), insulin 225 
(58%), and HbA1c (60.6%), and subgroup analysis did not reveal the source of the heterogeneity; 226 
conceivably impacting the accuracy of the results. Nuts. such as pistachios, are a rich source of 227 
magnesium and monounsaturated and polyunsaturated fatty acids, which can reduce insulin 228 
resistance, and improve carbohydrate metabolisms and insulin homeostasis (37). On the other 229 
hand, some of the positive effects of pistachios on glycemic control are mediated through the effect 230 
on the mRNA regulation.  Previous research has shown that some mRNA may be involved in 231 
protein cascades, especially in in the insulin signaling pathway. Some of the mRNA can reportedly 232 
regulate the expression of insulin receptors, insulin secretion, also in addition to regulating some 233 
proteins, such as Insulin Receptor Substrate 1 (IRS-1) and Phosphoinositide 3-Kinases 234 
(PI3Ks)(38). Pistachios are dense foods and possess many nutrients and bioactive compounds, for 235 
instance, omega-3 fatty acids found in pistachios have anti-inflammatory properties and can help 236 
to reduce insulin resistance (39). Moreover, pistachios are a rich source of polyphenols, which can 237 
improve glycaemia control and insulin sensitivity(40).  238 
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Lipid Profile 239 
Results of the present study showed that pistachios consumption yielded beneficial effects on 240 
TC/HDL and LDL/HDL ratios. However, there was a higher heterogeneity for TC/HDL and 241 
LDL/HDL ratios (95.3% and 96.3%, respectively). While measurement of serum lipids is a 242 
recommended part of cardiovascular risk detection, the predictive value of specific lipid measures 243 
remains controversial. Several studies have shown that changes in ratios of TC/HDL-C and LDL-244 
C/HDL-C are better predictors of CVD and Coronary Heart Disease (CHD) than individual 245 
markers (41-43).  There are some reasonable, putative, biological mechanisms for these effects; 246 
indeed, pistachio nuts contain good levels of dietary fiber, which has inhibitory effects on 247 
cholesterol absorption. Also, pistachios contain a higher amounts of phytosterols (up to 289 mg 248 
per 100 g of edible fruit). The amount of phytoestrol in pistachios is more than three times that of 249 
other nuts, such as walnuts or almonds (44). Phytosterols are one of the most potent plant bioactive 250 
compounds in reducing total cholesterol and LDL cholesterol, and can also increase HDL 251 
cholesterol levels by binding to estrogen receptors (45).  252 
Blood pressure 253 
According to our research, pistachios consumption can elicit significant effects on SBP, but not 254 
DBP. Although elevated arterial resistance is a characteristic of mixed systolic and diastolic 255 
hypertension in young people, raised arterial stiffness is the dominant hemodynamic factor and 256 
overrides resistance in elderly hypertensive patients, leading to a decrease in DBP, a rise in pulse 257 
pressure, and, therefore, independent systolic hypertension (46). Thus, pistachios consumption 258 
appears capable of maximizing the decrease in SBP and minimizing the reduction in DBP in direct 259 
proportion to the age-related stiffening of large arteries. The main fatty acids in pistachios include; 260 
palmitic, stearic, oleic, linoleic, and linolenic acids. Pistachio contains lower amounts of saturated 261 
fatty acids, such as palmitic acid, which play an important role in the incidence of cardiovascular 262 
disease. Additionally, pistachios contain higher amounts of arginine that can be converted into 263 
other bioactive products, such as nitric oxide, which acts as a vasodilator and an antiplatelet agen 264 
t(47). Moreover, the antioxidants in pistachios can reduce oxidative stress and formation of 265 
reactive oxygen species (ROS), which are both known to play an important role in the pathogenesis 266 
of cardiovascular disease and hypertension (48).  267 
Other factors 268 
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We did not find any significant effect of pistachios consumption on FMD and MDA. 269 
Concordantly, previous studies to have evaluated the effects of nuts on endothelial function have 270 
reported mixed results (49). Indeed, some of these studies reported positive effects (50) and some 271 
have reported null effects (48, 51). In line with our findings, Neale et al., in a systematic review 272 
and meta-analysis, evaluated the effects of nuts on endothelial function; accordingly, subgroup 273 
analyses revealed significant improvements in FMD, but only in those studies using walnuts (52). 274 
Finally, we also showed no significant effects of pistachios intake on CRP.  275 
Strengths and Limitations 276 
The present study had a number of strengths, including the use of the industry standard systematic 277 
methodology (PRISMA). Importantly, endothelial function was evaluated for the first time in this 278 
study, whilst we also considered a range of biomarkers that are associated with metabolic, 279 
inflammation, and endothelial function. These biomarkers are a good indicator of the progression 280 
of cardiovascular disease and metabolic syndrome. However, despite the strengths evident in the 281 
present study, there were some limitations that must be considered, including; higher heterogeneity 282 
in some biomarkers, lack of adequate studies to perform the meta-analysis in all areas regards the 283 
endothelial function, and differing sample sizes, populations, and health statuses. Additionally, 284 
this systematic review and meta-analysis did not perform a dose-response analysis, risk of bias for 285 
individual studies, and did not evaluate the strength of the evidence, which may represent viable 286 
opportunities for further investigation. 287 
 288 
Conclusion 289 
In conclusion, the current systematic review and meta-analysis suggests that a balanced 290 
consumption of pistachios nuts may be beneficial for lowering some cardio metabolic risk factors.  291 
Furthermore, the authors suggest that further studies, aimed to identifying the exact mechanisms 292 
involved in these beneficial effects, be conducted. 293 
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Table 1. Baseline Characteristics of Included Studies in the Meta-analysis 

















Blinding Type of 
population 
Outcomes  
Intervention  Control  
1 S. Gulati India 2014 24 Women/men 60 42.5 Standard diet + 20% 
daily caloric intake 
from pistachios per 
day 
Standard diet no MS Weight, WC, FBS, LDL-C, 
HDL-C, TG, TC, HBA1C, 
Insulin, HS-CRP 
2 Kasliwal, R. 
R. 
India 2015 12 Women/men 42 39 Life style 
modifications(LSM)
+ 80 gr pistachios 
per day 
LSM no mild 
dyslipidemi
a 
BMI, Weight, WC, FBS, 
LDL-C, HDL-C, TC/HDL, 
SBP, DBP, HS-CRP, FMD 
3 Kocyigit, A. Turkey 2006 3 Women/men 44 33.1 Normal diet+ 20% 
daily caloric intake 
from pistachios 
Normal diet no healthy LDL-C, HDL-C, TG, TC, 
LDL/HDL, TC/HDL, MDA 
4 Li, Z. USA 2010 12 Women/men 52 46.35 Weight reduction 
diet + 53gr 
pistachios per day 
Weight 
reduction diet+ 
56 gr of salted 
pretzels per day 
no obese BMI, Weight, FBS, LDL-C, 
HDL-C, TG, TC, Insulin 
5 Parham, M. Iran 2014 12 Women/men 44 51.5 Previous diet+ 2 
snacks of 25 gr 
pistachios per day 
Previous diet yes diabetics BMI, FBS, HBA1C, HOMA-
IR, SBP, DBP, HS-CRP,  








no healthy Weight, FBS, LDL-C, HDL-
C, TG, TC, LDL/HDL, 
TC/HDL, SBP, DBP, HS-
CRP, MDA 




diet + 20% daily 
caloric intake from 
pistachios 





no diabetics FMD 
8 Sauder, K. A. USA 2015 4 Women/men 30 56.1 American Heart  
Association’s 
Therapeutic 
American Heart  
Association’s 
Therapeutic 
no diabetics FBS, LDL-C, HDL-C, TG, 
TC, TC/HDL, HBA1C, 




diet + 20% daily 




9 Wang, X. china 2012 12 Women/men 90 51.46 received dietary 
counseling 
according to the 
guidelines of the 
American Heart 
Association + 42or 
70 gr pistachios per 
day 
 received dietary 
counseling 
according to the 
guidelines of the 
American Heart 
Association 
no MS FBS, LDL-C, TG, TC, 
Insulin,  
10 West, S. G. USA 2012 4 Women/men 28 - 10% (30% total fat) 
or 20% (34%total 











Spain 2014 16 Women/men 54 55 Normo-caloric diet 




no healthy BMI, Weight, WC, FBS, 
LDL-C, HDL-C, TG, TC, 
LDL/HDL, TC/HDL, 





















Table 2. quality of the studies 




























S. Gulati 2014 LOW UNCLEAR LOW LOW HIGH HIGH LOW Good 
Kasliwal, R. R.2015 LOW UNCLEAR LOW LOW HIGH HIGH LOW Good 
Kocyigit, A.2006 LOW UNCLEAR LOW LOW HIGH HIGH LOW Good 
Li, Z. 2010 LOW LOW LOW LOW HIGH HIGH LOW Good 
Parham, M.2014 LOW UNCLEAR LOW LOW LOW LOW LOW Good 
Sari, I.2010 UNCLEAR UNCLEAR LOW LOW HIGH HIGH LOW Fair  
Sauder, K. A.2014 LOW LOW LOW LOW HIGH HIGH LOW Good 
Sauder, K. A.2015 LOW LOW LOW LOW HIGH HIGH LOW Good 
Wang, X.2012 LOW UNCLEAR LOW LOW HIGH HIGH LOW Good 
West, S. G.2012 LOW UNCLEAR LOW LOW HIGH HIGH LOW Good 
Hernandez-Alonso, 
P.2014 
LOW LOW LOW LOW HIGH HIGH LOW Good  
